Pharmaceutical Industry Leaders Target Cutting-Edge MS Treatments That Once Were 'Fantasy'

Pharmaceutical Industry Leaders Target Cutting-Edge MS Treatments That Once Were 'Fantasy'

Multiple sclerosis can be crippling. But pharmaceutical industry leaders like Biogen, Novartis and Merck are working on MS treatments once only a "fantasy."